Subscribe To
Arrowhead pharmaceuticals, inc. (arwr) q1 2023 earnings call transcript
Arrowhead pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2023 Earnings Conference Call February 6, 2023 4:30 P...
February 6, 2023, 9:14 pm
Tonix pharmaceuticals initiates enrollment in phase 2 ‘prevention’ study of potentiated intranasal oxytocin (tnx-1900) for the prevention of migraine headaches in chronic migraineurs
Results from Planned Interim Analysis Expected Fourth Quarter 2023 Approximately Four Million in U.S. Suffer from Chronic Migraine Development of TNX-...
February 6, 2023, 12:00 pm
Why is catalent (nyse:ctlt) stock up 20% today?
Catalent (NYSE: CTLT ), which manufactures pharmaceutical products, is soaring more than 20% in early t...
February 6, 2023, 10:48 am
Recent price trend in scpharmaceuticals, inc. (scph) is your friend, here's why
scpharmaceuticals, Inc. (SCPH) could be a great choice for investors looking to make a profit from fund...
February 6, 2023, 10:32 am
Vistagen to report fiscal year 2023 third quarter financial results on february 7, 2023
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutic...
February 6, 2023, 9:09 am
Connect biopharma to present at svb securities global biopharma conference and participate in biocom california
SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage bio...
February 6, 2023, 8:30 am
Arbutus to participate in three upcoming investor conferences
WARMINSTER, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage bio...
February 6, 2023, 7:30 am
Immupharma partner agrees phase ii/iii clinical trial process
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) said partner Avion pharmaceuticals is to launch an adaptive phase I...
February 6, 2023, 2:18 am
The 7 most promising psychedelic stocks to buy in february
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several ...
February 5, 2023, 2:30 pm
Idorsia: interesting swiss biotech, but commercialization seems uncertain
Idorsia is a Swiss biopharmaceutical company with multiple commercial and pre-commercial assets. Idoris...
February 4, 2023, 6:06 am
Bragar eagel & squire, p.c. is investigating credit acceptance, and phathom and encourages investors to contact the firm
NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
February 4, 2023, 2:00 am
Bioasis announces agm results and provides update on financial position
NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-...
February 3, 2023, 10:39 pm
Bright green issues statement of intent on illegal short selling activities
GRANTS, N.M., Feb. 03, 2023 (GLOBE NEWSWIRE) — Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very fe...
February 3, 2023, 5:21 pm
Regeneron pharmaceuticals, inc. (regn) q4 2022 earnings call transcript
Regeneron pharmaceuticals, Inc. (NASDAQ:REGN ) Q4 2022 Earnings Conference Call February 3, 2023 8:30 A...
February 3, 2023, 12:43 pm
Here is what to know beyond why catalyst pharmaceuticals, inc. (cprx) is a trending stock
Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospect...
February 3, 2023, 10:32 am
Regeneron stock rallies after profit and revenue beat expectations by wide margins
Shares of Regeneron pharmaceuticals Inc. REGN, -0.90% rallied 1.9% toward a two-month high in premarket...
February 3, 2023, 6:45 am
Kalvista pharmaceuticals to present at svb securities global biopharma conference
CAMBRIDGE, Mass. & SALISBURY, England--( BUSINESS WIRE )--KalVista pharmaceuticals, Inc. (NASDAQ: KALV)...
February 3, 2023, 6:30 am
Reata pharmaceuticals, inc. (reta) soars 6.3%: is further upside left in the stock?
Reata pharmaceuticals, Inc. (RETA) saw its shares surge in the last session with trading volume being h...
February 3, 2023, 6:02 am
Structure therapeutics announces pricing of upsized initial public offering
SAN FRANCISCO and SHANGHAI, China, Feb. 02, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global bio...
February 3, 2023, 12:41 am
Takeda pharmaceutical company limited (tak) q3 2023 earnings call transcript
Takeda pharmaceutical Company Limited (NYSE:TAK ) Q3 2023 Earnings Conference Call February 2, 2023 5:3...
February 2, 2023, 11:54 pm